Metastatic Soft Tissue Sarcoma clinical trials

Explore recruiting metastatic soft tissue sarcoma clinical trials.

Recruiting metastatic soft tissue sarcoma studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Metastatic Soft Tissue Sarcoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase I study evaluating the safety and efficacy of MEDI5752 in combination with stereotactic radiotherapy in patients with metastatic sarcoma

France

Human Pharmacology (Phase I)- Other EU CTIS Study details

Sarcomas and DDR-Inhibition; a neoadjuvant phase I combined modality study - SADDRIN-1

Netherlands

Human Pharmacology (Phase I)- Other EU CTIS Study details

A Phase III study comparing the efficacy of the combination of doxorubicin and the tumor-targeting human antibody-cytokine fusion protein L19TNF to doxorubicin alone as first-line therapy in patients with advanced or metastatic soft tissue sarcoma

Spain, France, Germany, Poland, Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

CONGRATS : COMBINATION OF NIVOLUMAB PLUS RELATLIMAB IN PATIENTS WITH ADVANCED OR METASTATIC SOFT-TISSUE SARCOMA: A PROOF-OF-CONCEPT RANDOMIZED PHASE II STUDY

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A PHASE IB/II STUDY TO EVALUATE SAFETY AND EFFICACY OF BEXMARILIMAB IN COMBINATION WITH DOXORUBICIN IN METASTATIC SOFT-TISSUE SARCOMA (BEXAR Study)

Spain

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A randomized study to investigate the efficacy and safety of the tumor-targeting human antibody-cytokine fusion protein L19TNF in previously treated patients with advanced stage or metastatic soft-tissue sarcoma

Germany, Italy, Poland, Spain, France

Therapeutic exploratory (Phase II) EU CTIS Study details

Metastatic Soft Tissue Sarcoma trials by city

Metastatic Soft Tissue Sarcoma clinical trials

Recruiting metastatic soft tissue sarcoma studies right now

AB122 Platform Study

VAM in Secondary AML, AML With Extramedullary Involvement, and Myeloid Sarcoma

Minibeam Radiation Therapy With Tungsten Slit Collimator for the Treatment of Recurrent or Metastatic Skin or Soft Tissue Tumors

Iscador® P (Mistletoe) Immunotherapy for Recurrent Resectable Osteogenic Sarcoma

Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity

Pulmonary Resectable Osteosarcoma Treated by Metastasectomy and Pre-operative Immunotherapy and Stereotactic Body Radiotherapy (PROMIS): a Prospective Clinical Trial

Musculoskeletal Cancers Remote Monitoring and Care

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia

A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma

A First-In-Human Phase 1 Trial of T-Cell Membrane-Anchored Tumor Targeted Il12 (Attil12)- T-Cell Therapy in Subjects With Advanced/Metastatic Soft Tissue and Bone Sarcoma

Reduced Intensity Haploidentical BMT for High Risk Solid Tumors